Literature DB >> 23548615

Menopause is associated with decreased whole body fat oxidation during exercise.

J Abildgaard1, A T Pedersen, C J Green, N M Harder-Lauridsen, T P Solomon, C Thomsen, A Juul, M Pedersen, J T Pedersen, O H Mortensen, H Pilegaard, B K Pedersen, B Lindegaard.   

Abstract

The purpose of this study was to examine if fat oxidation was affected by menopausal status and to investigate if this could be related to the oxidative capacity of skeletal muscle. Forty-one healthy women were enrolled in this cross-sectional study [premenopausal (n = 19), perimenopausal (n = 8), and postmenopausal (n = 14)]. Estimated insulin sensitivity was obtained from an oral glucose tolerance test. Body composition was measured by dual-energy X-ray absorptiometry and magnetic resonance imaging. Fat oxidation and energy expenditure were measured during an acute exercise bout of 45 min of ergometer biking at 50% of maximal oxygen consumption (Vo2 max). Muscle biopsies from the vastus lateralis of the quadriceps muscle were obtained before and immediately after the exercise bout. Postmenopausal women had 33% [confidence interval (CI) 95%: 12-55] lower whole body fat oxidation (P = 0.005) and 19% (CI 95%: 9-22) lower energy expenditure (P = 0.02) during exercise, as well as 4.28 kg lower lean body mass (LBM) than premenopausal women. Correction for LBM reduced differences in fat oxidation to 23% (P = 0.05), whereas differences in energy expenditure disappeared (P = 0.22). No differences between groups were found in mRNA [carnitine palmitoyltransferase I, β-hydroxyacyl-CoA dehydrogenase (β-HAD), peroxisome proliferator-activated receptor-α, citrate synthase (CS), pyruvate dehydrogenase kinase 4, peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α)], protein [phosphorylated AMP-activated protein kinase (AMPK), vascular endothelial growth factor, pyruvate dehydrogenase-1Eα, cytochrome oxidase I], or enzyme activities (β-HAD, CS) in resting skeletal muscle, except for an increased protein level of cytochrome c in the post- and perimenopausal women relative to premenopausal women. Postmenopausal women demonstrated a trend to a blunted exercise-induced increase in phosphorylation of AMPK compared with premenopausal women (P = 0.06). We conclude that reduced whole body fat oxidation after menopause is associated with reduced LBM.

Entities:  

Keywords:  biopsy; fat oxidation; menopause; skeletal muscle

Mesh:

Year:  2013        PMID: 23548615     DOI: 10.1152/ajpendo.00492.2012

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  18 in total

1.  Predictors of serum polychlorinated biphenyl concentrations in Anniston residents.

Authors:  M Pavuk; J R Olson; W A Wattigney; N D Dutton; A Sjödin; C Shelton; W E Turner; S M Bartell
Journal:  Sci Total Environ       Date:  2014-08-09       Impact factor: 7.963

Review 2.  Metabolic control and sex: A focus on inflammatory-linked mediators.

Authors:  Darren C Henstridge; Julie Abildgaard; Birgitte Lindegaard; Mark A Febbraio
Journal:  Br J Pharmacol       Date:  2019-04-21       Impact factor: 8.739

Review 3.  The sexual dimorphism of obesity.

Authors:  Biff F Palmer; Deborah J Clegg
Journal:  Mol Cell Endocrinol       Date:  2015-01-08       Impact factor: 4.102

4.  Factors Influencing Substrate Oxidation During Submaximal Cycling: A Modelling Analysis.

Authors:  Jeffrey A Rothschild; Andrew E Kilding; Tom Stewart; Daniel J Plews
Journal:  Sports Med       Date:  2022-07-12       Impact factor: 11.928

5.  Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women.

Authors:  Leilah K Grant; Jamie E Coborn; Aviva Cohn; Margo D Nathan; Frank A J L Scheer; Elizabeth B Klerman; Ursula B Kaiser; Jessica Harder; Mathena Abramson; Elkhansaa Elguenaoui; Julia A Russell; Aleta Wiley; Shadab A Rahman; Hadine Joffe
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

6.  Preclinical efficacy of the GPER-selective agonist G-1 in mouse models of obesity and diabetes.

Authors:  Geetanjali Sharma; Chelin Hu; Daniela I Staquicini; Jonathan L Brigman; Meilian Liu; Franck Mauvais-Jarvis; Renata Pasqualini; Wadih Arap; Jeffrey B Arterburn; Helen J Hathaway; Eric R Prossnitz
Journal:  Sci Transl Med       Date:  2020-01-29       Impact factor: 17.956

Review 7.  Gender differences in skeletal muscle substrate metabolism - molecular mechanisms and insulin sensitivity.

Authors:  Anne-Marie Lundsgaard; Bente Kiens
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-13       Impact factor: 5.555

8.  In vitro palmitate treatment of myotubes from postmenopausal women leads to ceramide accumulation, inflammation and affected insulin signaling.

Authors:  Julie Abildgaard; Darren C Henstridge; Anette T Pedersen; Katherine G Langley; Camilla Scheele; Bente Klarlund Pedersen; Birgitte Lindegaard
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

9.  Lower resting and total energy expenditure in postmenopausal compared with premenopausal women matched for abdominal obesity.

Authors:  Leanne Hodson; Karin Harnden; Rajarshi Banerjee; Belen Real; Kyriakoula Marinou; Fredrik Karpe; Barbara A Fielding
Journal:  J Nutr Sci       Date:  2014-02-13

10.  Female sex hormones are necessary for the metabolic effects mediated by loss of Interleukin 18 signaling.

Authors:  Birgitte Lindegaard; Julie Abildgaard; Sarah E Heywood; Bente K Pedersen; Mark A Febbraio
Journal:  Mol Metab       Date:  2018-04-12       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.